BRAF inhibition increases tumor infiltrating lymphocytes, putative markers of T‐cell exhaustion, and PD‐ L‐1 expression 30 and different BRAF inhibitors may produce differential effects on lymphocyte counts 31, the implications of which are unclear regarding the use of these ratios in sequencing or combining treatments. Here, BRAF is linked to neoplasm.